APO Research
Talk to an analyst

APO RESEARCH · REPORT

Live Cell Encapsulation

Live cell encapsulation has long been proposed as a solution in modern medicine to many therapeutic problems. Cell encapsulation technology is used for the immobilization of cells within biocompatible and semipermeable membranes. The encapsulation of cells, instead of therapeutic products, is used to allow the delivery of molecules of interest for a longer time period as cells release these molecules of interest continuously. Furthermore, cells can be engineered for expressing the protein of interest in vivo without modifying the host’s genome. Cell encapsulation presents a significant advantage compared to protein encapsulation, as cell encapsulation allows a sustained and controlled delivery therapeutic molecules at a constant rate, thereby resulting in greater physiological concentrations.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Live cell encapsulation has long been proposed as a solution in modern medicine to many therapeutic problems. Cell encapsulation technology is used for the immobilization of cells within biocompatible and semipermeable membranes. The encapsulation of cells, instead of therapeutic products, is used to allow the delivery of molecules of interest for a longer time period as cells release these molecules of interest continuously. Furthermore, cells can be engineered for expressing the protein of interest in vivo without modifying the host’s genome. Cell encapsulation presents a significant advantage compared to protein encapsulation, as cell encapsulation allows a sustained and controlled delivery therapeutic molecules at a constant rate, thereby resulting in greater physiological concentrations.

The Live Cell Encapsulation industry can be broken down into several segments, Alginate, HEMA-MMA, etc.

Across the world, the major players cover BioTime, Reed Pacific, Viacyte, etc.

Selected research

Market Outlook & Growth Opportunities

Global Live Cell Encapsulation Market Outlook and Growth Opportunities 2026

30 December 2025197 pages

Choose your research edition.

Industry ResearchLive Cell Encapsulation Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Live Cell Encapsulation Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Live Cell Encapsulation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Live Cell Encapsulation Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Live Cell Encapsulation Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

Live cell encapsulation has long been proposed as a solution in modern medicine to many therapeutic problems. Cell encapsulation technology is used for the immobilization of cells within biocompatible and semipermeable membranes. The encapsulation of cells, instead of therapeutic products, is used to allow the delivery of molecules of interest for a longer time period as cells release these molecules of interest continuously. Furthermore, cells can be engineered for expressing the protein of interest in vivo without modifying the host’s genome. Cell encapsulation presents a significant advantage compared to protein encapsulation, as cell encapsulation allows a sustained and controlled delivery therapeutic molecules at a constant rate, thereby resulting in greater physiological concentrations.

The Live Cell Encapsulation industry can be broken down into several segments, Alginate, HEMA-MMA, etc.

Across the world, the major players cover BioTime, Reed Pacific, Viacyte, etc.

Read the full market overview

Global Live Cell Encapsulation key players include Viacyte, Inc., Living Cell Technologies Ltd., Sigilon Therapeutics, Inc, Sernova Corporation, PharmaCyte Biotech Inc, Gloriana Therapeutics, Kadimastem, Beta-O2 Technologies, Inc., Altucell, Inc., Diatranz Otsuka Ltd, etc.

This report provides an overview of the global Live Cell Encapsulation market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Live Cell Encapsulation and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Live Cell Encapsulation revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Live Cell Encapsulation market.

Live Cell Encapsulation Segment by Company

Viacyte, Inc.

Living Cell Technologies Ltd.

Sigilon Therapeutics, Inc

Sernova Corporation

PharmaCyte Biotech Inc

Gloriana Therapeutics

Kadimastem

Beta-O2 Technologies, Inc.

Altucell, Inc.

Diatranz Otsuka Ltd

Live Cell Encapsulation Segment by Type

Alginate

Chitosan

Cellulose

Others

Live Cell Encapsulation Segment by Application

Diabetes

Cancer

Epilepsy

Parkinson

Others

Live Cell Encapsulation Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Live Cell Encapsulation status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Live Cell Encapsulation key companies, revenue, market share, and recent developments.

3. To split the Live Cell Encapsulation breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Live Cell Encapsulation market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Live Cell Encapsulation significant trends, drivers, influence factors in global and regions.

6. To analyze Live Cell Encapsulation competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Live Cell Encapsulation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Live Cell Encapsulation and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Live Cell Encapsulation.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Live Cell Encapsulation industry.

Chapter 3: Detailed analysis of Live Cell Encapsulation company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Live Cell Encapsulation in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Live Cell Encapsulation in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Live Cell Encapsulation Industry Trends Table 2. Live Cell Encapsulation Industry Drivers Table 3. Live Cell Encapsulation Industry Opportunities and Challenges Table 4. Live Cell Encapsulation Industry Restraints Table 5. Global Live Cell Encapsulation Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Live Cell Encapsulation Revenue Share by Company (2021-2026) Table 7. Global Live Cell Encapsulation Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Live Cell Encapsulation Key Company Manufacturing Base & Headquarters Table 9. Global Live Cell Encapsulation Company, Product Type & Application Table 10. Global Live Cell Encapsulation Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Live Cell Encapsulation by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Alginate Table 15. Significant Companies of Chitosan Table 16. Significant Companies of Cellulose Table 17. Significant Companies of Others Table 18. Global Live Cell Encapsulation Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Live Cell Encapsulation Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Live Cell Encapsulation Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Live Cell Encapsulation Sales Value Share by Type (2021-2026) Table 22. Global Live Cell Encapsulation Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Diabetes Table 24. Significant Companies of Cancer Table 25. Significant Companies of Epilepsy Table 26. Significant Companies of Parkinson Table 27. Significant Companies of Others Table 28. Global Live Cell Encapsulation Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Live Cell Encapsulation Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global Live Cell Encapsulation Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global Live Cell Encapsulation Sales Value Share by Application (2021-2026) Table 32. Global Live Cell Encapsulation Sales Value Share by Application (2027-2032) Table 33. Global Live Cell Encapsulation Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Live Cell Encapsulation Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global Live Cell Encapsulation Sales Value Share by Region (2021-2026) Table 36. Global Live Cell Encapsulation Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global Live Cell Encapsulation Sales Value Share by Region (2027-2032) Table 38. Global Live Cell Encapsulation Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Live Cell Encapsulation Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global Live Cell Encapsulation Sales Value Market Share by Country (2021-2026) Table 41. Global Live Cell Encapsulation Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global Live Cell Encapsulation Sales Value Market Share by Country (2027-2032) Table 43. Viacyte, Inc. Company Information Table 44. Viacyte, Inc. Business Overview Table 45. Viacyte, Inc. Live Cell Encapsulation Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Viacyte, Inc. Live Cell Encapsulation Product Portfolio Table 47. Viacyte, Inc. Recent Development Table 48. Living Cell Technologies Ltd. Company Information Table 49. Living Cell Technologies Ltd. Business Overview Table 50. Living Cell Technologies Ltd. Live Cell Encapsulation Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Living Cell Technologies Ltd. Live Cell Encapsulation Product Portfolio Table 52. Living Cell Technologies Ltd. Recent Development Table 53. Sigilon Therapeutics, Inc Company Information Table 54. Sigilon Therapeutics, Inc Business Overview Table 55. Sigilon Therapeutics, Inc Live Cell Encapsulation Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Sigilon Therapeutics, Inc Live Cell Encapsulation Product Portfolio Table 57. Sigilon Therapeutics, Inc Recent Development Table 58. Sernova Corporation Company Information Table 59. Sernova Corporation Business Overview Table 60. Sernova Corporation Live Cell Encapsulation Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. Sernova Corporation Live Cell Encapsulation Product Portfolio Table 62. Sernova Corporation Recent Development Table 63. PharmaCyte Biotech Inc Company Information Table 64. PharmaCyte Biotech Inc Business Overview Table 65. PharmaCyte Biotech Inc Live Cell Encapsulation Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. PharmaCyte Biotech Inc Live Cell Encapsulation Product Portfolio Table 67. PharmaCyte Biotech Inc Recent Development Table 68. Gloriana Therapeutics Company Information Table 69. Gloriana Therapeutics Business Overview Table 70. Gloriana Therapeutics Live Cell Encapsulation Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Gloriana Therapeutics Live Cell Encapsulation Product Portfolio Table 72. Gloriana Therapeutics Recent Development Table 73. Kadimastem Company Information Table 74. Kadimastem Business Overview Table 75. Kadimastem Live Cell Encapsulation Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Kadimastem Live Cell Encapsulation Product Portfolio Table 77. Kadimastem Recent Development Table 78. Beta-O2 Technologies, Inc. Company Information Table 79. Beta-O2 Technologies, Inc. Business Overview Table 80. Beta-O2 Technologies, Inc. Live Cell Encapsulation Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Beta-O2 Technologies, Inc. Live Cell Encapsulation Product Portfolio Table 82. Beta-O2 Technologies, Inc. Recent Development Table 83. Altucell, Inc. Company Information Table 84. Altucell, Inc. Business Overview Table 85. Altucell, Inc. Live Cell Encapsulation Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Altucell, Inc. Live Cell Encapsulation Product Portfolio Table 87. Altucell, Inc. Recent Development Table 88. Diatranz Otsuka Ltd Company Information Table 89. Diatranz Otsuka Ltd Business Overview Table 90. Diatranz Otsuka Ltd Live Cell Encapsulation Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Diatranz Otsuka Ltd Live Cell Encapsulation Product Portfolio Table 92. Diatranz Otsuka Ltd Recent Development Table 93. Research Programs/Design for This Report Table 94. Authors List of This Report Table 95. Secondary Sources Table 96. Primary Sources List of Figures Figure 1. Live Cell Encapsulation Product Image Figure 2. Global Live Cell Encapsulation Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Live Cell Encapsulation Market Size (2021-2032) & (US$ Million) Figure 4. Global Live Cell Encapsulation Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Alginate Image Figure 8. Chitosan Image Figure 9. Cellulose Image Figure 10. Others Image Figure 11. Global Live Cell Encapsulation Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Live Cell Encapsulation Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Live Cell Encapsulation Sales Value Share by Type (2021-2032) Figure 14. Diabetes Image Figure 15. Cancer Image Figure 16. Epilepsy Image Figure 17. Parkinson Image Figure 18. Others Image Figure 19. Global Live Cell Encapsulation Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Live Cell Encapsulation Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Live Cell Encapsulation Sales Value Share by Application (2021-2032) Figure 22. Global Live Cell Encapsulation Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Live Cell Encapsulation Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America Live Cell Encapsulation Sales Value (2021-2032) & (US$ Million) Figure 25. North America Live Cell Encapsulation Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe Live Cell Encapsulation Sales Value (2021-2032) & (US$ Million) Figure 27. Europe Live Cell Encapsulation Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific Live Cell Encapsulation Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific Live Cell Encapsulation Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America Live Cell Encapsulation Sales Value (2021-2032) & (US$ Million) Figure 31. South America Live Cell Encapsulation Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa Live Cell Encapsulation Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Live Cell Encapsulation Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA Live Cell Encapsulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada Live Cell Encapsulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico Live Cell Encapsulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany Live Cell Encapsulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France Live Cell Encapsulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. Live Cell Encapsulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy Live Cell Encapsulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain Live Cell Encapsulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia Live Cell Encapsulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands Live Cell Encapsulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries Live Cell Encapsulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China Live Cell Encapsulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan Live Cell Encapsulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea Live Cell Encapsulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India Live Cell Encapsulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia Live Cell Encapsulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia Live Cell Encapsulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil Live Cell Encapsulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina Live Cell Encapsulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile Live Cell Encapsulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia Live Cell Encapsulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru Live Cell Encapsulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Live Cell Encapsulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel Live Cell Encapsulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE Live Cell Encapsulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey Live Cell Encapsulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran Live Cell Encapsulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt Live Cell Encapsulation Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • Alginate
  • Chitosan
  • Cellulose
  • Others
Applications
  • Diabetes
  • Cancer
  • Epilepsy
  • Parkinson
  • Others
Companies covered
  • Viacyte, Inc.
  • Living Cell Technologies Ltd.
  • Sigilon Therapeutics, Inc
  • Sernova Corporation
  • PharmaCyte Biotech Inc
  • Gloriana Therapeutics
  • Kadimastem
  • Beta-O2 Technologies, Inc.
  • Altucell, Inc.
  • Diatranz Otsuka Ltd

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Live Cell Encapsulation Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Live Cell Encapsulation Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Live Cell Encapsulation Market Dynamics
  1. 2.1 Live Cell Encapsulation Industry Trends
  2. 2.2 Live Cell Encapsulation Industry Drivers
  3. 2.3 Live Cell Encapsulation Industry Opportunities and Challenges
  4. 2.4 Live Cell Encapsulation Industry Restraints
3 Live Cell Encapsulation Market by Company
  1. 3.1 Global Live Cell Encapsulation Company Revenue Ranking in 2025
  2. 3.2 Global Live Cell Encapsulation Revenue by Company (2021-2026)
  3. 3.3 Global Live Cell Encapsulation Company Ranking (2024-2026)
  4. 3.4 Global Live Cell Encapsulation Company Manufacturing Base and Headquarters
  5. 3.5 Global Live Cell Encapsulation Company Product Type and Application
  6. 3.6 Global Live Cell Encapsulation Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Live Cell Encapsulation Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Live Cell Encapsulation Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Live Cell Encapsulation Market by Type
  1. 4.1 Live Cell Encapsulation Type Introduction
  2. 4.1.1 Alginate
  3. 4.1.2 Chitosan
  4. 4.1.3 Cellulose
  5. 4.1.4 Others
  6. 4.2 Global Live Cell Encapsulation Sales Value by Type
  7. 4.2.1 Global Live Cell Encapsulation Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Live Cell Encapsulation Sales Value by Type (2021-2032)
  9. 4.2.3 Global Live Cell Encapsulation Sales Value Share by Type (2021-2032)
5 Live Cell Encapsulation Market by Application
  1. 5.1 Live Cell Encapsulation Application Introduction
  2. 5.1.1 Diabetes
  3. 5.1.2 Cancer
  4. 5.1.3 Epilepsy
  5. 5.1.4 Parkinson
  6. 5.1.5 Others
  7. 5.2 Global Live Cell Encapsulation Sales Value by Application
  8. 5.2.1 Global Live Cell Encapsulation Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Live Cell Encapsulation Sales Value by Application (2021-2032)
  10. 5.2.3 Global Live Cell Encapsulation Sales Value Share by Application (2021-2032)
6 Live Cell Encapsulation Regional Value Analysis
  1. 6.1 Global Live Cell Encapsulation Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Live Cell Encapsulation Sales Value by Region (2021-2032)
  3. 6.2.1 Global Live Cell Encapsulation Sales Value by Region: 2021-2026
  4. 6.2.2 Global Live Cell Encapsulation Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Live Cell Encapsulation Sales Value (2021-2032)
  7. 6.3.2 North America Live Cell Encapsulation Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Live Cell Encapsulation Sales Value (2021-2032)
  10. 6.4.2 Europe Live Cell Encapsulation Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Live Cell Encapsulation Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Live Cell Encapsulation Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Live Cell Encapsulation Sales Value (2021-2032)
  16. 6.6.2 South America Live Cell Encapsulation Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Live Cell Encapsulation Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Live Cell Encapsulation Sales Value Share by Country, 2025 VS 2032
7 Live Cell Encapsulation Country-level Value Analysis
  1. 7.1 Global Live Cell Encapsulation Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Live Cell Encapsulation Sales Value by Country (2021-2032)
  3. 7.2.1 Global Live Cell Encapsulation Sales Value by Country (2021-2026)
  4. 7.2.2 Global Live Cell Encapsulation Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Live Cell Encapsulation Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Live Cell Encapsulation Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Live Cell Encapsulation Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Live Cell Encapsulation Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Live Cell Encapsulation Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Live Cell Encapsulation Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Live Cell Encapsulation Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Live Cell Encapsulation Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Live Cell Encapsulation Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Live Cell Encapsulation Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Live Cell Encapsulation Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Live Cell Encapsulation Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Live Cell Encapsulation Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Live Cell Encapsulation Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Live Cell Encapsulation Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Live Cell Encapsulation Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Live Cell Encapsulation Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Live Cell Encapsulation Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Live Cell Encapsulation Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Live Cell Encapsulation Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Live Cell Encapsulation Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Live Cell Encapsulation Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Live Cell Encapsulation Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Live Cell Encapsulation Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Live Cell Encapsulation Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Live Cell Encapsulation Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Live Cell Encapsulation Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Live Cell Encapsulation Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Live Cell Encapsulation Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Live Cell Encapsulation Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Viacyte, Inc.
  2. 8.1.1 Viacyte, Inc. Company Information
  3. 8.1.2 Viacyte, Inc. Business Overview
  4. 8.1.3 Viacyte, Inc. Live Cell Encapsulation Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Viacyte, Inc. Live Cell Encapsulation Product Portfolio
  6. 8.1.5 Viacyte, Inc. Recent Developments
  7. 8.2 Living Cell Technologies Ltd.
  8. 8.2.1 Living Cell Technologies Ltd. Company Information
  9. 8.2.2 Living Cell Technologies Ltd. Business Overview
  10. 8.2.3 Living Cell Technologies Ltd. Live Cell Encapsulation Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Living Cell Technologies Ltd. Live Cell Encapsulation Product Portfolio
  12. 8.2.5 Living Cell Technologies Ltd. Recent Developments
  13. 8.3 Sigilon Therapeutics, Inc
  14. 8.3.1 Sigilon Therapeutics, Inc Company Information
  15. 8.3.2 Sigilon Therapeutics, Inc Business Overview
  16. 8.3.3 Sigilon Therapeutics, Inc Live Cell Encapsulation Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Sigilon Therapeutics, Inc Live Cell Encapsulation Product Portfolio
  18. 8.3.5 Sigilon Therapeutics, Inc Recent Developments
  19. 8.4 Sernova Corporation
  20. 8.4.1 Sernova Corporation Company Information
  21. 8.4.2 Sernova Corporation Business Overview
  22. 8.4.3 Sernova Corporation Live Cell Encapsulation Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sernova Corporation Live Cell Encapsulation Product Portfolio
  24. 8.4.5 Sernova Corporation Recent Developments
  25. 8.5 PharmaCyte Biotech Inc
  26. 8.5.1 PharmaCyte Biotech Inc Company Information
  27. 8.5.2 PharmaCyte Biotech Inc Business Overview
  28. 8.5.3 PharmaCyte Biotech Inc Live Cell Encapsulation Revenue and Gross Margin (2021-2026)
  29. 8.5.4 PharmaCyte Biotech Inc Live Cell Encapsulation Product Portfolio
  30. 8.5.5 PharmaCyte Biotech Inc Recent Developments
  31. 8.6 Gloriana Therapeutics
  32. 8.6.1 Gloriana Therapeutics Company Information
  33. 8.6.2 Gloriana Therapeutics Business Overview
  34. 8.6.3 Gloriana Therapeutics Live Cell Encapsulation Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Gloriana Therapeutics Live Cell Encapsulation Product Portfolio
  36. 8.6.5 Gloriana Therapeutics Recent Developments
  37. 8.7 Kadimastem
  38. 8.7.1 Kadimastem Company Information
  39. 8.7.2 Kadimastem Business Overview
  40. 8.7.3 Kadimastem Live Cell Encapsulation Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Kadimastem Live Cell Encapsulation Product Portfolio
  42. 8.7.5 Kadimastem Recent Developments
  43. 8.8 Beta-O2 Technologies, Inc.
  44. 8.8.1 Beta-O2 Technologies, Inc. Company Information
  45. 8.8.2 Beta-O2 Technologies, Inc. Business Overview
  46. 8.8.3 Beta-O2 Technologies, Inc. Live Cell Encapsulation Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Beta-O2 Technologies, Inc. Live Cell Encapsulation Product Portfolio
  48. 8.8.5 Beta-O2 Technologies, Inc. Recent Developments
  49. 8.9 Altucell, Inc.
  50. 8.9.1 Altucell, Inc. Company Information
  51. 8.9.2 Altucell, Inc. Business Overview
  52. 8.9.3 Altucell, Inc. Live Cell Encapsulation Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Altucell, Inc. Live Cell Encapsulation Product Portfolio
  54. 8.9.5 Altucell, Inc. Recent Developments
  55. 8.10 Diatranz Otsuka Ltd
  56. 8.10.1 Diatranz Otsuka Ltd Company Information
  57. 8.10.2 Diatranz Otsuka Ltd Business Overview
  58. 8.10.3 Diatranz Otsuka Ltd Live Cell Encapsulation Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Diatranz Otsuka Ltd Live Cell Encapsulation Product Portfolio
  60. 8.10.5 Diatranz Otsuka Ltd Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst